BRC-Pipeline-background.jpg

Developing the Next Generation of Cannabinoid Therapeutics

 

Bold Strategy
Innovation in Research
Cannabinoid Therapeutics

THIS IS BRC.


About Us

BRC’s mission is to address unmet medical needs using innovative cannabinoid therapeutics — safely and effectively. We have full DEA compliance for botanically derived cannabinoids (phytocannabinoids).

BRC has developed proprietary poly-cannabinoids in titratable standardized dosages that are soon to enter the clinic.

Meet the Team

BRC’s management team is made up of experienced professionals from the pharmaceutical  and regulated cannabinoid industries. This unique combination will be key for BRC to becoming the leading botanically derived cannabinoid therapeutics company in the United States.